Evidence map›Paper›PMID 36497379›Full record

ArticleCancers2022

CT-Based Radiomic Analysis for Preoperative Prediction of Tumor Invasiveness in Lung Adenocarcinoma Presenting as Pure Ground-Glass Nodule.

Tzu-Ning Kao, Min-Shu Hsieh, Li-Wei Chen, Chi-Fu Jeffrey Yang, Ching-Chia Chuang, Xu-Heng Chiang, Yi-Chang Chen, Yi-Hsuan Lee, Hsao-Hsun Hsu, Chung-Ming Chen and 2 more

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
4.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Tzu-Ning KaoDepartment of Surgery, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei 100225, Taiwan.
Min-Shu HsiehDepartment of Pathology, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei 100225, Taiwan.
Li-Wei ChenInstitute of Biomedical Engineering, College of Medicine and College of Engineering, National Taiwan University, Taipei 106319, Taiwan.ORCID 0000-0002-3618-0256
Chi-Fu Jeffrey YangDepartment of Thoracic Surgery, Massachusetts General Hospital, Boston, MA 02114, USA.
Ching-Chia ChuangInstitute of Biomedical Engineering, College of Medicine and College of Engineering, National Taiwan University, Taipei 106319, Taiwan.
Xu-Heng ChiangInstitute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University, Taipei 100025, Taiwan.
Yi-Chang ChenInstitute of Biomedical Engineering, College of Medicine and College of Engineering, National Taiwan University, Taipei 106319, Taiwan.ORCID 0000-0003-1380-3737
Yi-Hsuan LeeDepartment of Pathology, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei 100225, Taiwan.
Hsao-Hsun HsuDepartment of Surgery, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei 100225, Taiwan.
Chung-Ming ChenInstitute of Biomedical Engineering, College of Medicine and College of Engineering, National Taiwan University, Taipei 106319, Taiwan.ORCID 0000-0002-0023-5817
Mong-Wei LinDepartment of Surgery, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei 100225, Taiwan.ORCID 0000-0003-1268-3729
Jin-Shing ChenDepartment of Surgery, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei 100225, Taiwan.
National Taiwan University · TWNational Taiwan University Hospital · TWMassachusetts General Hospital · US

Funding

National Taiwan University Hospital NTUH110-S5037the Ministry of Science and Technology, Taiwan MOST 110-2314-B-002-271
6 · The paper itself

Abstract

It remains a challenge to preoperatively forecast whether lung pure ground-glass nodules (pGGNs) have invasive components. We aimed to construct a radiomic model using tumor characteristics to predict the histologic subtype associated with pGGNs. We retrospectively reviewed clinicopathologic features of pGGNs resected in 338 patients with lung adenocarcinoma between 2011-2016 at a single institution. A radiomic prediction model based on forward sequential selection and logistic regression was constructed to differentiate adenocarcinoma in situ (AIS)/minimally invasive adenocarcinoma (MIA) from invasive adenocarcinoma. The study cohort included 133 (39.4%), 128 (37.9%), and 77 (22.8%) patients with AIS, MIA, and invasive adenocarcinoma (acinar 55.8%, lepidic 33.8%, papillary 10.4%), respectively. The majority (83.7%) underwent sublobar resection. There were no nodal metastases or tumor recurrence during a mean follow-up period of 78 months. Three radiomic features-cluster shade, homogeneity, and run-length variance-were identified as predictors of histologic subtype and were selected to construct a prediction model to classify the AIS/MIA and invasive adenocarcinoma groups. The model achieved accuracy, sensitivity, specificity, and AUC of 70.6%, 75.0%, 70.0%, and 0.7676, respectively. Applying the developed radiomic feature model to predict the histologic subtypes of pGGNs observed on CT scans can help clinically in the treatment selection process.

Indexed as

ground-glass noduleinvasivenesslung adenocarcinomalung cancer surgeryradiomic feature analysis

Identifiers

PMID36497379
PMCPMC9739513
OpenAlexW4310384200

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.